Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.255 USD | +2.97% | 0.00% | +25.56% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 54.34M |
---|---|---|---|---|---|
Net income 2024 * | -47M | Net income 2025 * | -73M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.94
x | P/E ratio 2025 * |
-1.96
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.45% |
Latest transcript on Eledon Pharmaceuticals, Inc.
1 day | +1.83% | ||
1 week | -1.33% | ||
Current month | -6.69% | ||
1 month | +35.98% | ||
3 months | +25.99% | ||
6 months | +78.40% | ||
Current year | +23.89% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-04-30 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 21-03-14 |
Steven N. Perrin
PSD | President | 59 | 20-09-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 17-04-30 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 20-09-13 |
John S. McBride
BRD | Director/Board Member | 72 | 17-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 2.26 | +3.20% | 67 755 |
24-05-13 | 2.19 | -5.19% | 237,726 |
24-05-10 | 2.31 | -3.75% | 197,005 |
24-05-09 | 2.4 | -1.64% | 171,171 |
24-05-08 | 2.44 | +7.96% | 405,517 |
Delayed Quote Nasdaq, May 14, 2024 at 10:55 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.89% | 54.34M | |
+4.54% | 111B | |
+11.14% | 105B | |
-12.28% | 22.34B | |
-3.52% | 21.93B | |
-6.17% | 18.59B | |
-35.21% | 18.12B | |
-9.38% | 16.96B | |
+3.01% | 13.7B | |
+36.28% | 12.45B |
- Stock Market
- Equities
- ELDN Stock